Clinical value of cytokine antagonists in infectious complications

Research Communications in Molecular Pathology and Pharmacology

Volumn 96, Issue 1, 1997, Pages 25-34

  Iwagaki, Hiromi ^a   Hizuta, Akio ^a   Uomoto, Masashi ^a   Takeuchi, Yoshiaki ^a   Kohoka, Hideo ^a   Okamoto, Takahiro ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFECTIOUS COMPLICATION; INFLAMMATORY DISEASE; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL;

ADULT; AGED; BACTERIAL INFECTIONS; CYTOKINES; FEMALE; HOMEOSTASIS; HUMANS; HYDROCORTISONE; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-2;

EID: 0030914452     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Adams, D.H., Mainolfi, E.A., Elias, E., Neuberger, J.M. and Rothlein, R. (1993). Detection of circulating intercellular adhesion molecule-1 after liver transplantation-evidence of local release within the liver during graft rejection. Transplantation. 55, 83-87.
2. Alexander, H.R., Doherty, G.M., Venzon, D.J., Merino, M.J., Fraker, D.L. and Norton, J.A. (1992). Recombinant Interleukin-1 receptor antagonist (IL-1ra):effective therapy against gram-negative sepsis in rats. Surgery. 112, 188-194.
3. Bean, A. G., Freiberg, R.A., Andrade, S., Menon, S. and Zlotnik, A. (1993). Interleukin-10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61, 4937-4939.
4. Becker, J. C., Termeer, C., Scmidt, R.E. and Brocker, E.B. (1993) Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T-cell/tumor interaction. J. Immunol. 151, 7224-7232.
5. Bogdan, C., Vodovotz, Y. and Nathan, C. (1991). Macrophage deactivation by interleukin 10. J. Exp. Med. 174, 1549-1555.
6. Bone, R.C. (1991). The pathogenesis of sepsis. Ann. Intern. Med. 115, 457-469.
7. Bone, R.C. (1994). Gram-positive organisms and sepsis. Arch. Intern. Med. 154, 26-34.
8. Brandtzaeg, P., Kierulf, P. and Gaustad, P (1989). Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J. Infect. Dis. 159, 195-204.
9. Cassatella, M.A., Meda, L., Bonora, S., Ceska, M. and Constantin, G. (1993). Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178, 2207-2211.
10. Chernoff, A.E., Granowitz, E.V. and Shapiro, L. (1995). A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154, 5492-5499.
11. Cominelli, F., Nast, C.C., Duchini, A. and Lee, M. (1992) Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology. 103, 5-71.
12. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C.G. and de Vries, J.E. (1991). Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
13. Dofferhoff, A.S., Bom, V.J. and de Vries-Hospers, H.G. (1992). Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor and acute-phase proteins during the treatment of severe sepsis in humans. Crit. Care. Med. 20, 185-192.
14. Dripps, D.J., Brandhuber, B.J., Thompson, R.C. and Eisenberg, S.P. (1991). Effect of IL-1ra on IL-1 signal transduction. J. Biol. Chem. 266, 10331-10336.
15. Durno, A.G., Ho, D.R., Schocley, R.T., Hirsch, M.S., Mackeen, L. and Ip, S.H. (1986). Serum interleukin-2 receptor (IL-2R) levels in human immunodeficiency virus (HIV) infection. Blood. 68, 124-126.
16. Dustin, M.C., Rothlein, R., Bahn, A.K., Dinarello, A. and Springer, T.A. (1986). Induction by IL-1 and interferon-g tissue distribution, biochemistry and function of natural adhesion molecule (ICAM-1). J. Immunol. 137, 245-254.
17. Eisenberg, S.P., Brewer, M.T., Verderber, E., Heimdal, P., Brandhuber, B.J., and Thompson, R.C. (1991). Interleukin-1 receptor antagonist is a member of the interleukin-1 gene family:evolution of a cytokine control mechanism. Proc. Natl. Acad. Sci. USA . 88, 5232-5236.
18. Fiorentiono, D.F., Zlotnik, A. and Vieira, P. (1991). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444-3451.
19. Girardin, E., Grau, G.E., Dayer, J.M., Roux-Lombard, P. and Lambert, P.H. (1988). Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319, 397-400.
20. Gerard, C., Bruyns, C. and Marchant, A. (1993). Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177, 547-550.
21. Granowitz, E.V., Clark, B.D., Mancilla, J. and Dinarello, C.A. (1991). Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J. Biol. Chem. 266, 14147-14150.
22. Howard, M., Muchamuel, T., Andrade, S. and Menon, S. (1993). Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177, 1205-1208.
23. Henderson, B., Thompson, R.C., Hardingham, T. and Lewthwaite, J. (1991). Inhibition of interleukin-1 induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine. 3,246-249.
24. Herold, M. and Mur, E. (1991). sICAM-1 levels in patients with rheumatoid arthritis. Int. Workshop on Adhesion Molecules, Vienna, abstr. 15.
25. Halstensen, A., Ceska, M., Brandtzaeg, P., Redl, H., Naess, A. and Waage, A. (1993). Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. J. Infect. Dis. 167, 471-475.
26. Iwagaki, H., Hizuta, A., Iwadou, H., Perdomo, J.A., Tanaka, N. and Orita, K. (1994). Clinical value of soluble interleukin-2 receptor in infectious complications. Acta. Med. Okayama. 48(4), 225-226.
27. Iwagaki, H., Hizuta, A., Tanaka, N., Orita, K., Gotoh, K., Morimoto, N., Tokioka, H., and Hirakawa, M. (1994). Elevated levels of cytokines in plasma from patients with severe infections. Jpn. J. Infect. Res. 6, 15-20.
28. Kling, E., Bieg S., Boehme, M. and Scherbaum, W.A. (1993). Circulating intercellular adhesion molecule-1 as a new disease marker in patients with systemic lupus erythromatosis. Clin. Invest. 71, 299-304.
29. Nelson, D.L., Rubin, L.A., Kurman, C.C., Fritz, M.E. and Boutin, B. (1986). An analysis of the cellular requirements for the production of soluble interleukin-2 receptors in vitro. J. Clin. Immunol. 6, 114-120.
30. Olive, D., Lopez, M., Blaise, D., Viens, P., Stoppa, A.M., Brandely, M., Mawas, C., Mannoni, P. and Maraninchi, D. (1991). Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is upregulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2. J. Immunother. 10, 412-417.
31. Pober, J.S., Gimbrone, M.A., Lapierre, L.A., Mendrick, D.L., Fiers, W., Rothlein, R. and Springer, T.A. (1986). Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor and immune interferon. J. Immunol. 137, 1893-1896.
32. Rothlein, R., Mainolfi, E.A., Czaikowski, M. and Marlin, S.O. (1991). A form of circulating ICAM-1 in human serum. J. Immunol. 147, 3788-3793.
33. Rubin, L.A., Kurman, C.C., Fritz, M.E., Biddison, W.E., Boutin, B., Yarchoan, R. and Nelson, D.L. (1985). Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 135, 3172-3177.
34. Rubin, L.A., Jay, G. and Nelson, D.L. (1986). The released interleukin-2 receptor binds interleukin-1 efficiently. J. Immunol. 137, 3841-3845.
35. Rothlein, R., Czaikowski, M, O'Neill, M.M., Marlin, S.D., Mainolfi, E. and Merluzzi, V.J. (1988). Induction of intercellular adhesion molecule-1 on primary and continuous cell lines by proinflammatory cytokines. Regulation by pharmacological agents and neutralizing antibodies. J. Immunol. 141, 1665-1669.
36. Seth, R., Raymond, F.D. and Makgoba, M.W. (1991). Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 338, 83-84.
37. Vieira, P., de Waal-Malefyt, R. and Dang, M.N. (1991). Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA. 88, 1172-1176.
38. Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P. and Espevik, T. (1989). The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1 and fatal outcome. J. Exp. Med. 169, 333-338.
39. Wallgren, A.C., Festin, R., Gidlof, C. Dohlsten, M., Kalland, T. and Totterman, T.H. (1993). Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells. Blood 82, 1230-1238.
40. Welder, C.A., Lee, D.H.J. and Takei, F. (1993). Inhibition of cell adhesion by microspheres coated with recombinant soluble intercellular adhesion molecule-1. J. Immunol. 150, 2203-2210.